Chugai Pharmaceutical Co....

PNK: CHGCF · Real-Time Price · USD
56.39
0.54 (0.97%)
At close: May 01, 2025, 3:20 PM
0.97%
Bid 56.3
Market Cap 92.8B
Revenue (ttm) 1,084.6B
Net Income (ttm) 355.04B
EPS (ttm) 1.73
PE Ratio (ttm) 32.6
Forward PE n/a
Analyst n/a
Ask 61.22
Volume 1,260
Avg. Volume (20D) 7,842
Open 61.15
Previous Close 55.85
Day's Range 56.34 - 61.15
52-Week Range 29.75 - 72.30
Beta 0.70

About CHGCF

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis a...

Sector Healthcare
IPO Date Aug 3, 2012
Employees 5,026
Stock Exchange PNK
Ticker Symbol CHGCF
Full Company Profile